Cargando…
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
Acute respiratory distress syndrome virus-2 (SARS-CoV-2) responsible for coronavirus disease 2019 (COVID-19) infection, which causes global public health emergencies, has sped widely for more than 5 months and has the risk of long-term transmission. No effective treatment has been discovered to date...
Autores principales: | Peng, Hongbing, Gong, Tiefeng, Huang, Xiaoying, Sun, Xun, Luo, Hong, Wang, Weizhong, Luo, Junbiao, Luo, Baowei, Chen, Yanhui, Wang, Xingxing, Long, Haifeng, Mei, Hua, Li, Chuang, Dai, Yanni, Li, Honghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365301/ https://www.ncbi.nlm.nih.gov/pubmed/32678017 http://dx.doi.org/10.1186/s13287-020-01802-8 |
Ejemplares similares
-
Incubation period, clinical and lung CT features for early prediction of COVID-19 deterioration: development and internal verification of a risk model
por: Peng, Hongbing, et al.
Publicado: (2022) -
Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis
por: Wenjing, Luo, et al.
Publicado: (2020) -
Post-COVID syndrome: Turning convalescence into illness?
por: Cozzi, Giorgio, et al.
Publicado: (2021) -
Post-COVID syndrome: Turning convalescence into illness? – Authors’ reply
por: Augustin, Max, et al.
Publicado: (2021) -
Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)